NCT02600689
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
Clinical trial condition
Idiopathic Pulmonary Fibrosis
Explore clinical trials studying Idiopathic Pulmonary Fibrosis. Study availability and eligibility vary by location and protocol.
330 public trials
44 recruiting studies
Idiopathic Pulmonary Fibrosis trial results
Completed
Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
NCT02739165
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- Nagoya, Aichi-ken, Japan
- Seto, Aichi-ken, Japan
- Kamogawa, Chiba, Japan
- Sakura, Chiba, Japan
NCT02802345
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Pulmonary Assoc of Stamford Stamford, Connecticut, United States
- University of Florida College of Medicine Jacksonville, Florida, United States
- University of Chicago Chicago, Illinois, United States
NCT01134822
- Conditions
- Fibrosis, Idiopathic Pulmonary Fibrosis, Lung Diseases, +5 more
- Locations
-
- Nottingham University Hospitals NHS Trust Nottingham, United Kingdom
NCT00540475
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- Milton S. Hershey Medical Center Hershey, Pennsylvania, United States
- University of Pennsylvania Health System Philadelphia, Pennsylvania, United States
- Temple University Philadelphia, Pennsylvania, United States
- Dorothy P. & Richard P. Simmons Center for Interstitial Lung Disease Pittsburgh, Pennsylvania, United States
NCT01872689
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- University Alabama At Birmingham Birmingham, Alabama, United States
- Mayo Clinic- Scottsdale Scottsdale, Arizona, United States
- Southern Arizona Veterans Administration Healthcare Systems Tucson, Arizona, United States
- University of Arizona Tucson, Arizona, United States
NCT02598193
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- David Geffen School of Medicine at UCLA;Division of Pulmonary & Critical Care/ Department of Medic Los Angeles, California, United States
- Stanford University School of Medicine ; Pulmonary/Critical Care Medicine Stanford, California, United States
- Sarasota Memorial Hospital Sarasota, Florida, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT02058602
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- GSK Investigational Site Edegem, Belgium
NCT01919827
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- Servicio de Neumología, Clínica Universidad de Navarra Pamplona, Navarre, Spain
- Servicio de Neumología. Hospital Universitario de Salamanaca Salamanca, Spain
Completed
Nintedanib Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)
NCT01979952
- Conditions
- Idiopathic Pulmonary Fibrosis, Lung Diseases, Lung Diseases, Interstitial, +2 more
- Locations
-
- Western CT Medical Group, P.C. Danbury, Connecticut, United States
- Clinical Research Center Sarasota Memorial Hosptial Sarasota, Florida, United States
- Chest Medicine Clinical Services Skokie, Illinois, United States
- Baptist Health Lexington Lexington, Kentucky, United States